FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044932421> ?p ?o ?g. }

• W2044932421 endingPage "1165" @default.
• W2044932421 startingPage "1157" @default.
• W2044932421 abstract "Both virological failure and the toxicity of HIV protease inhibitors have been related to interindividual variability of plasma drug concentrations. Therapeutic drug monitoring (TDM) offers the possibility to detect patients with drug concentrations outside therapeutic ranges, who can subsequently benefit from dose modifications.ATHENA was a randomized controlled clinical trial. Subjects were randomly assigned to either a TDM group, in which the results of drug concentration measurements plus advice were reported to their treating physician, or to a control group for whom TDM results were not reported. This analysis refers to treatment-naive patients who started a regimen containing indinavir or nelfinavir before November 1999.A total of 147 patients were randomly assigned: 92 to nelfinavir, 55 to indinavir. After one year of follow-up significantly fewer patients in the TDM group had discontinued nelfinavir or indinavir than in the control group: 17.4 versus 39.7%. This was mainly driven by a significantly lower rate of discontinuation because of virological failure in nelfinavir patients: 2.4% in the TDM group versus 17.6% in the control group, and by a non-significant difference in the rate of discontinuation because of toxicity in indinavir patients: 14.3% in the TDM group versus 29.6% in the control group. In a non-completer equals failure analysis of all randomized patients, the TDM group showed a significantly higher proportion of patients with a viral load below 500 copies after 12 months of treatment (78.2 versus 55.1%).TDM of nelfinavir and indinavir in treatment-naive patients improves treatment response." @default.
• W2044932421 created "2016-06-24" @default.
• W2044932421 creator A5001375239 @default.
• W2044932421 creator A5006129004 @default.
• W2044932421 creator A5016878897 @default.
• W2044932421 creator A5021568119 @default.
• W2044932421 creator A5035631448 @default.
• W2044932421 creator A5044892605 @default.
• W2044932421 creator A5047002646 @default.
• W2044932421 creator A5067277048 @default.
• W2044932421 creator A5073785042 @default.
• W2044932421 creator A5078789624 @default.
• W2044932421 creator A5080080592 @default.
• W2044932421 creator A5089148378 @default.
• W2044932421 date "2003-05-01" @default.
• W2044932421 modified "2023-09-26" @default.
• W2044932421 title "Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals" @default.
• W2044932421 cites W1871950822 @default.
• W2044932421 cites W1997151749 @default.
• W2044932421 cites W1997868582 @default.
• W2044932421 cites W2013417313 @default.
• W2044932421 cites W2013569100 @default.
• W2044932421 cites W2014842368 @default.
• W2044932421 cites W2025152688 @default.
• W2044932421 cites W2025351576 @default.
• W2044932421 cites W2026219081 @default.
• W2044932421 cites W2046493152 @default.
• W2044932421 cites W2051678628 @default.
• W2044932421 cites W2063329141 @default.
• W2044932421 cites W2063543191 @default.
• W2044932421 cites W2078326422 @default.
• W2044932421 cites W2080008894 @default.
• W2044932421 cites W2095709318 @default.
• W2044932421 cites W2104808569 @default.
• W2044932421 cites W2118379411 @default.
• W2044932421 cites W2127840648 @default.
• W2044932421 cites W2133448156 @default.
• W2044932421 cites W2148928395 @default.
• W2044932421 cites W2151105520 @default.
• W2044932421 cites W2155122198 @default.
• W2044932421 cites W2165589438 @default.
• W2044932421 cites W2167733897 @default.
• W2044932421 cites W2317784465 @default.
• W2044932421 cites W2318022415 @default.
• W2044932421 cites W2318289184 @default.
• W2044932421 cites W2321838878 @default.
• W2044932421 cites W3026032990 @default.
• W2044932421 cites W4243187239 @default.
• W2044932421 doi "https://doi.org/10.1097/00002030-200305230-00007" @default.
• W2044932421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12819517" @default.
• W2044932421 hasPublicationYear "2003" @default.
• W2044932421 type Work @default.
• W2044932421 sameAs 2044932421 @default.
• W2044932421 citedByCount "146" @default.
• W2044932421 countsByYear W20449324212012 @default.
• W2044932421 countsByYear W20449324212013 @default.
• W2044932421 countsByYear W20449324212014 @default.
• W2044932421 countsByYear W20449324212015 @default.
• W2044932421 countsByYear W20449324212016 @default.
• W2044932421 countsByYear W20449324212017 @default.
• W2044932421 countsByYear W20449324212018 @default.
• W2044932421 countsByYear W20449324212019 @default.
• W2044932421 countsByYear W20449324212020 @default.
• W2044932421 countsByYear W20449324212021 @default.
• W2044932421 crossrefType "journal-article" @default.
• W2044932421 hasAuthorship W2044932421A5001375239 @default.
• W2044932421 hasAuthorship W2044932421A5006129004 @default.
• W2044932421 hasAuthorship W2044932421A5016878897 @default.
• W2044932421 hasAuthorship W2044932421A5021568119 @default.
• W2044932421 hasAuthorship W2044932421A5035631448 @default.
• W2044932421 hasAuthorship W2044932421A5044892605 @default.
• W2044932421 hasAuthorship W2044932421A5047002646 @default.
• W2044932421 hasAuthorship W2044932421A5067277048 @default.
• W2044932421 hasAuthorship W2044932421A5073785042 @default.
• W2044932421 hasAuthorship W2044932421A5078789624 @default.
• W2044932421 hasAuthorship W2044932421A5080080592 @default.
• W2044932421 hasAuthorship W2044932421A5089148378 @default.
• W2044932421 hasBestOaLocation W20449324211 @default.
• W2044932421 hasConcept C126322002 @default.
• W2044932421 hasConcept C142462285 @default.
• W2044932421 hasConcept C168563851 @default.
• W2044932421 hasConcept C203014093 @default.
• W2044932421 hasConcept C2776452011 @default.
• W2044932421 hasConcept C2777210460 @default.
• W2044932421 hasConcept C2778715236 @default.
• W2044932421 hasConcept C2780035454 @default.
• W2044932421 hasConcept C2780272996 @default.
• W2044932421 hasConcept C2780727368 @default.
• W2044932421 hasConcept C2781143361 @default.
• W2044932421 hasConcept C2781160516 @default.
• W2044932421 hasConcept C2993143319 @default.
• W2044932421 hasConcept C3013748606 @default.
• W2044932421 hasConcept C71924100 @default.
• W2044932421 hasConcept C98274493 @default.
• W2044932421 hasConceptScore W2044932421C126322002 @default.
• W2044932421 hasConceptScore W2044932421C142462285 @default.
• W2044932421 hasConceptScore W2044932421C168563851 @default.
• W2044932421 hasConceptScore W2044932421C203014093 @default.

• next